(Q34102780)

31 July 2017

1 reference

title

Treatment of infections in the patient with Mendelian susceptibility to mycobacterial infection (English)

1 reference

31 July 2017

1 reference

S M Holland

1

1 reference

31 July 2017

1 November 2000

1 reference

31 July 2017

Microbes and Infection

1 reference

31 July 2017

2

1 reference

31 July 2017

13

1 reference

31 July 2017

1579-1590

1 reference

Disseminated infection with Mycobacterium avium-intracellulare. A report of 13 cases and a review of the literature

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Mendelian susceptibility to mycobacterial infection in man

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Current and future clinical applications of interferon-gamma in host antimicrobial defense

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Cellular responses to interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Studies of IFN-induced transcriptional activation uncover the Jak-Stat pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Attempts to characterize the mechanisms involved in mycobacterial growth inhibition by gamma-interferon-activated bone marrow macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Transient loss of resistance to pulmonary tuberculosis in p47(phox-/-) mice

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Oxidative and non-oxidative intracellular killing of Mycobacterium avium complex

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Cytokine modulation of Mycobacterium tuberculosis growth in human macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Disseminated tuberculosis in interferon gamma gene-disrupted mice

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guérin and subsequent challenge with lipopolysaccharide.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Requirement for transcription factor IRF-1 in NO synthase induction in macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

A Controlled Trial of Interferon Gamma to Prevent Infection in Chronic Granulomatous Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Safety and effectiveness of long-term interferon gamma therapy in patients with chronic granulomatous disease

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Interferon-gamma in the management of infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

The Influence of Thalidomide on the Clinical and Immunologic Manifestation of Erythema Nodosum Leprosum

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Thalidomide stimulates T cell responses and interleukin 12 production in HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Thalidomide-induced antigen-specific immune stimulation in patients with human immunodeficiency virus type 1 and tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Disseminated bacille Calmette-Guérin disease after vaccination: case report and review

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Interferon-gamma and Mycobacterium avium-intracellulare infection

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Interferon-gamma treatment for Mycobacterium avium-intracellular complex bacillemia in patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Abnormal regulation of interferon-gamma, interleukin-12, and tumor necrosis factor-alpha in human interferon-gamma receptor 1 deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Familial disseminated atypical mycobacterial infection in childhood: a human mycobacterial susceptibility gene?

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Familial disseminated infection due to atypical mycobacteria with childhood onset

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Inherited interleukin 12 deficiency in a child with bacille Calmette-Guérin and Salmonella enteritidis disseminated infection

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Infection with Mycobacterium avium complex in patients without predisposing conditions

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Pectus excavatum and scoliosis. Thoracic anomalies associated with pulmonary disease caused by Mycobacterium avium complex

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Mycobacterium avium Complex Pulmonary Disease Presenting as an Isolated Lingular or Middle Lobe Pattern

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Polyclonal Mycobacterium avium complex infections in patients with nodular bronchiectasis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Analyses of the NRAMP1 and IFN-gammaR1 genes in women with Mycobacterium avium-intracellulare pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Familial pulmonary Mycobacterium avium complex disease

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Mycobacterium avium-intracellulare pulmonary infection in HIV-negative patients without preexisting lung disease: diagnostic and management limitations

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Organ specific cytokine therapy. Local activation of mononuclear phagocytes by delivery of an aerosol of recombinant interferon-gamma to the human lung

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Aerosolized interferon gamma for Mycobacterium avium-complex lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Use of adjunctive treatment with interferon-gamma in an immunocompromised patient who had refractory multidrug-resistant tuberculosis of the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Stimulation with cytokines enhances penetration of azithromycin into human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Immunochemotherapy for intracellular Leishmania donovani infection: gamma interferon plus pentavalent antimony

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Effect of Treatment with Interferon- Alone in Visceral Leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Transcriptional responses to polypeptide ligands: the JAK-STAT pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Selective expression of an interleukin-12 receptor component by human T helper 1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Effects of aerosolized interferon-alpha in patients with pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Lysis of mycobacteria-infected monocytes by IL-2-activated killer cells: role of LFA-1

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Cytokine activation of killer cells in mycobacterial immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Leprosy and cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

The systemic influence of recombinant interleukin 2 on the manifestations of lepromatous leprosy

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Rational immunotherapy with interleukin 2

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Intradermal recombinant interleukin 2 enhances peripheral blood T-cell responses to mitogen and antigens in patients with lepromatous leprosy

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Recombinant interleukin 2 adjunctive therapy in multidrug-resistant tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon gamma and tumor necrosis factor alpha.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Recombinant granulocyte-macrophage colony-stimulating factor activates human macrophages to inhibit growth or kill Mycobacterium avium complex

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Recombinant granulocyte-macrophage colony-stimulating factor enhances the effects of antibiotics against Mycobacterium avium complex infection in the beige mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Dysfunctional monocytes from a patient with disseminated Mycobacterium kansasii infection are activated in vitro and in vivo by GM-CSF.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Immunomodulatory treatment of Mycobacterium avium complex bacteremia in patients with AIDS by use of recombinant granulocyte-macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Isolated cutaneous response to granulocyte-monocyte colony stimulating factor in fatal idiopathic disseminated Bacillus-Calmette-Guerin infection

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Immunomodulation by thalidomide and thalidomide analogues

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Listeria monocytogenes and recurrent mycobacterial infections in a child with complete interferon-gamma-receptor (IFNgammaR1) deficiency: mutational analysis and evaluation of therapeutic options

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma- and tumor necrosis factor (TNF)-alpha-dependent host resistance to the intracellular pathogen, Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2901314-9

7 January 2021

10.1016/S1286-4579(00)01314-9

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11113377